WeCareAdvisor for Caregiver Support in Dementia
NG
SK
WS
Overseen ByWeCareAdvisor Study Team
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Drexel University
No Placebo Group
Trial Summary
What is the purpose of this trial?
The WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia. The trial will evaluate its efficacy to reduce caregiver distress, improve confidence managing behaviors, as well as reduce occurrences and severity of behavioral and psychological symptoms. Visit https://wecareadvisorstudy.com/ for more information.
Research Team
LN
Laura N Gitlin, PhD
Principal Investigator
Drexel University
HC
Helen C Kales, MD
Principal Investigator
University of California, Davis
Eligibility Criteria
This trial is for primary caregivers who have been caring for someone with dementia for at least 6 months, can use a smartphone or computer with internet, and speak English. They must not be planning to move the person into long-term care soon, be in another similar study, or have severe visual/hearing impairments.Inclusion Criteria
You have experienced more than one behavioral symptom in the past month.
I have been on a stable dose of my mental health medication for at least 60 days.
Lives in the United States or US territory
See 6 more
Exclusion Criteria
The person with dementia is at risk of attempting suicide, as reported by their caregiver.
You are currently helping with a different study about helping people with memory problems.
The person I care for with dementia does not respond to their surroundings.
See 3 more
Treatment Details
Interventions
- WeCareAdvisor Study (Behavioural Intervention)
Trial OverviewThe WeCareAdvisor online tool is being tested to see if it helps caregivers manage dementia-related behaviors better. Caregivers are split into groups: some get immediate prompts from the tool; others wait three months before starting. The intensity of these prompts varies between high and low.
Participant Groups
4Treatment groups
Experimental Treatment
Group I: Waitlist Control after three months with high-Intensity promptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and telephone and email prompts.
Group II: Waitlist Control after three months with Low-Intensity PromptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and email prompts only.
Group III: Immediate treatment group with Low-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive email prompts only.
Group IV: Immediate treatment group with High-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive telephone and email prompts.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Drexel University
Lead Sponsor
Trials
160
Recruited
48,600+
University of California, Davis
Collaborator
Trials
958
Recruited
4,816,000+
National Institute on Aging (NIA)
Collaborator
Trials
1,841
Recruited
28,150,000+
Johns Hopkins University
Collaborator
Trials
2,366
Recruited
15,160,000+